Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-14

Clinical Trial Update: Effects of Cholinergic Augmentation on Measures of Balance and Gait [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effects of cholinergic augmentation on balance and gait in Parkinson's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-11-14